youtube_live
Q3 2026 earnings • released • EPS beat +8,63% • Revenue beat +3,25%
See resultschevron_right
NOT:ETR
Novartis AG
143,18 €
arrow_upward
+2,59%(+3,62) 1D
29-окт., 17:35:45 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOT...
Open
141,98 €
High
145,78 €
Low
141,98 €
Mkt. cap
327,81 млд
Avg. vol.
5,16 миң
Volume
12,56 миң
52-wk high
145,78 €
52-wk low
104,52 €
No. of employees
75 миң
Open
141,98 €
High
145,78 €
Low
141,98 €
Mkt. cap
327,81 млд
Avg. vol.
5,16 миң
Volume
12,56 миң
52-wk high
145,78 €
52-wk low
104,52 €
No. of employees
75 миң
News stories
From web sources and news partners
Seeking Alpha
·
19 саат мурун
Novartis AG 2026 Q3 - Results - Earnings Call Presentation (NYSE:NVS) 2026-10-29
Yahoo Finance
·
2 күн мурун
Novartis AG (NVS) Stock Forecasts
TradingView
·
2 күн мурун
What Novartis (NVS) Said on Its Q3 Earnings Call
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75,3 миң
Founded1996-ж., 7-мар.
HeadquartersБазель, Базель-Штадт, Швейцария
SectorPharmaceutical industry
Websitenovartis.com